Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Delia Goletti and Linda Petrone.
Delia Goletti
Connection Strength
7.003
Linda Petrone
  1. Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S82-S87.
    View in: PubMed
    Score: 0.934
  2. In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy. J Infect. 2021 04; 82(4):58-66.
    View in: PubMed
    Score: 0.931
  3. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients. Clin Microbiol Infect. 2021 Feb; 27(2):286.e7-286.e13.
    View in: PubMed
    Score: 0.907
  4. First description of agonist and antagonist IP-10 in urine of patients with active TB. Int J Infect Dis. 2019 Jan; 78:15-21.
    View in: PubMed
    Score: 0.785
  5. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection. Tuberculosis (Edinb). 2018 07; 111:147-153.
    View in: PubMed
    Score: 0.772
  6. The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses. Clin Microbiol Infect. 2021 Dec; 27(12):1784-1789.
    View in: PubMed
    Score: 0.239
  7. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection. J Transl Med. 2021 06 26; 19(1):272.
    View in: PubMed
    Score: 0.238
  8. In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses. Biomed Res Int. 2021; 2021:8856018.
    View in: PubMed
    Score: 0.238
  9. Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients. Int J Infect Dis. 2021 May; 106:338-347.
    View in: PubMed
    Score: 0.235
  10. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Eur Respir J. 2020 10; 56(4).
    View in: PubMed
    Score: 0.226
  11. QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis. J Infect. 2019 11; 79(5):444-453.
    View in: PubMed
    Score: 0.210
  12. Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice. Expert Opin Drug Saf. 2019 05; 18(5):415-425.
    View in: PubMed
    Score: 0.205
  13. Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs. Expert Rev Anti Infect Ther. 2018 06; 16(6):501-512.
    View in: PubMed
    Score: 0.193
  14. Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics. Mediators Inflamm. 2017; 2017:8909834.
    View in: PubMed
    Score: 0.180
  15. Long-lasting tuberculous pleurisy. Eur Respir J. 2017 05; 49(5).
    View in: PubMed
    Score: 0.179
  16. Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine. Microorganisms. 2021 Jun 16; 9(6).
    View in: PubMed
    Score: 0.059
  17. Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis. J Immunol. 2021 05 15; 206(10):2420-2429.
    View in: PubMed
    Score: 0.059
  18. World Tuberculosis Day 2021 Theme - 'The Clock is Ticking' - and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic. Int J Infect Dis. 2021 12; 113 Suppl 1:S1-S6.
    View in: PubMed
    Score: 0.058
  19. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review. Drugs. 2020 Dec; 80(18):1929-1946.
    View in: PubMed
    Score: 0.057
  20. IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay. Int J Med Microbiol. 2019 Jul; 309(5):299-306.
    View in: PubMed
    Score: 0.052
  21. Severe chest allodynia as an unusual first presentation of hydatid disease: a case report. BMC Infect Dis. 2019 Jan 09; 19(1):37.
    View in: PubMed
    Score: 0.050
  22. Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis. Front Immunol. 2018; 9:2427.
    View in: PubMed
    Score: 0.049
  23. PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis. Cell Microbiol. 2018 Dec; 20(12):e12952.
    View in: PubMed
    Score: 0.049
  24. Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions. Front Immunol. 2018; 9:1456.
    View in: PubMed
    Score: 0.048
  25. Impaired IFN-a-mediated signal in dendritic cells differentiates active from latent tuberculosis. PLoS One. 2018; 13(1):e0189477.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.